Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2016

01-11-2016 | Original Article

Expected lifetime numbers, risks, and burden of osteoporotic fractures for 50-year old Chinese women: a discrete event simulation incorporating FRAX

Authors: Yawen Jiang, Weiyi Ni

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2016

Login to get access

Abstract

This work was undertaken to provide an estimation of expected lifetime numbers, risks, and burden of fractures for 50-year-old Chinese women. A discrete event simulation model was developed to simulate the lifetime fractures of 50-year-old Chinese women at average risk of osteoporotic fracture. Main events in the model included hip fracture, clinical vertebral fracture, wrist fracture, humerus fracture, and other fracture. Fracture risks were calculated using the FRAX® tool. Simulations of 50-year-old Chinese women without fracture risks were also carried out as a comparison to determine the burden of fractures. A 50-year-old Chinese woman at average risk of fracture is expected to experience 0.135 (95 % CI: 0.134–0.137) hip fractures, 0.120 (95 % CI: 0.119–0.122) clinical vertebral fractures, 0.095 (95 % CI: 0.094–0.096) wrist fractures, 0.079 (95 % CI: 0.078–0.080) humerus fractures, and 0.407 (95 % CI: 0.404–0.410) other fractures over the remainder of her life. The residual lifetime risk of any fracture, hip fracture, clinical vertebral fracture, wrist fracture, humerus fracture, and other fracture for a 50-year-old Chinese woman is 37.36, 11.77, 10.47, 8.61, 7.30, and 27.80 %, respectively. The fracture-attributable excess quality-adjusted life year (QALY) loss and lifetime costs are estimated at 0.11 QALYs (95 % CI: 0.00–0.22 QALYs) and US $714.61 (95 % CI: US $709.20–720.02), totaling a net monetary benefit loss of US $1,104.43 (95 % CI: US $904.09–1,304.78). Chinese women 50 years of age are at high risk of osteoporotic fracture, and the expected economic and quality-of-life burden attributable to osteoporotic fractures among Chinese women is substantial.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. The Lancet 359:1929–1936CrossRef Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. The Lancet 359:1929–1936CrossRef
3.
go back to reference Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. The Lancet 359:1761–1767CrossRef Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. The Lancet 359:1761–1767CrossRef
4.
go back to reference Mithal A, Ebeling P, Kyer C (2013) The Asia-Pacific regional audit: epidemiology, costs, and burden of osteoporosis in 2013. International osteoporosis foundation, Nyon Mithal A, Ebeling P, Kyer C (2013) The Asia-Pacific regional audit: epidemiology, costs, and burden of osteoporosis in 2013. International osteoporosis foundation, Nyon
5.
go back to reference Liang H, Zhong W, Ning L (2009) Statistics on the expenses for medical care of osteoporotic fractures in Beijing Jishuitan Hospital (from 2000 to 2006) [J]. J Pract Orthop 5:000 Liang H, Zhong W, Ning L (2009) Statistics on the expenses for medical care of osteoporotic fractures in Beijing Jishuitan Hospital (from 2000 to 2006) [J]. J Pract Orthop 5:000
6.
go back to reference Lips P, van Schoor NM (2005) Quality of life in patients with osteoporosis. Osteoporos Int 16:447–455CrossRefPubMed Lips P, van Schoor NM (2005) Quality of life in patients with osteoporosis. Osteoporos Int 16:447–455CrossRefPubMed
7.
go back to reference Burge R et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed
8.
go back to reference Chrischilles EA et al (1991) A model of lifetime osteoporosis impact. Arch Intern Med 151:2026–2032CrossRefPubMed Chrischilles EA et al (1991) A model of lifetime osteoporosis impact. Arch Intern Med 151:2026–2032CrossRefPubMed
9.
go back to reference Bleibler F et al (2014) Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model. BMC Health Serv Res 14:284CrossRefPubMedPubMedCentral Bleibler F et al (2014) Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model. BMC Health Serv Res 14:284CrossRefPubMedPubMedCentral
10.
go back to reference Bleibler F et al (2013) The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany—a demographic simulation model. Osteoporos Int 24:835–847CrossRefPubMed Bleibler F et al (2013) The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany—a demographic simulation model. Osteoporos Int 24:835–847CrossRefPubMed
11.
go back to reference Schwenkglenks M et al (2005) A model of osteoporosis impact in Switzerland 2000–2020. Osteoporos Int 16:659–671CrossRefPubMed Schwenkglenks M et al (2005) A model of osteoporosis impact in Switzerland 2000–2020. Osteoporos Int 16:659–671CrossRefPubMed
12.
go back to reference Qu B et al (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int 25:1853–1860CrossRefPubMed Qu B et al (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int 25:1853–1860CrossRefPubMed
13.
go back to reference Dai K et al (2007) Estimation of resource utilization associated with osteoporotic hip fracture and level of post-acute care in China. Curr Med Res Opin® 23:2937–2943CrossRef Dai K et al (2007) Estimation of resource utilization associated with osteoporotic hip fracture and level of post-acute care in China. Curr Med Res Opin® 23:2937–2943CrossRef
14.
go back to reference Ji M-X, Yu Q (2015) Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med 1:9–13CrossRef Ji M-X, Yu Q (2015) Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med 1:9–13CrossRef
16.
go back to reference Caro JJ (2005) Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 23:323–332CrossRefPubMed Caro JJ (2005) Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 23:323–332CrossRefPubMed
17.
go back to reference Sobolev B, Sanchez V, Kuramoto L (2012) Health Care Evaluation Using Computer Simulation: Concepts, Methods, and Applications. Springer, New YorkCrossRef Sobolev B, Sanchez V, Kuramoto L (2012) Health Care Evaluation Using Computer Simulation: Concepts, Methods, and Applications. Springer, New YorkCrossRef
18.
go back to reference Caro JJ, Möller J, Getsios D (2010) Discrete event simulation: the preferred technique for health economic evaluations? Value Health 13:1056–1060CrossRefPubMed Caro JJ, Möller J, Getsios D (2010) Discrete event simulation: the preferred technique for health economic evaluations? Value Health 13:1056–1060CrossRefPubMed
19.
go back to reference Hiligsmann M et al (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 12:687–696CrossRefPubMed Hiligsmann M et al (2009) Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 12:687–696CrossRefPubMed
20.
go back to reference Van Gestel A et al (2010) Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma. Value Health 13:358–367CrossRefPubMed Van Gestel A et al (2010) Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma. Value Health 13:358–367CrossRefPubMed
21.
go back to reference Kung AW et al (2007) Ten-year risk of osteoporotic fractures in postmenopausal Chinese women according to clinical risk factors and BMD T Scores: a prospective study. J Bone Miner Res 22:1080–1087CrossRefPubMed Kung AW et al (2007) Ten-year risk of osteoporotic fractures in postmenopausal Chinese women according to clinical risk factors and BMD T Scores: a prospective study. J Bone Miner Res 22:1080–1087CrossRefPubMed
23.
go back to reference Zhao F-L et al (2011) Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis. Med Care 49:267–272CrossRefPubMed Zhao F-L et al (2011) Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis. Med Care 49:267–272CrossRefPubMed
24.
go back to reference Ström O et al (2010) FRAX® and its applications in health economics–cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example. Bone 47:430–437CrossRefPubMed Ström O et al (2010) FRAX® and its applications in health economics–cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example. Bone 47:430–437CrossRefPubMed
25.
go back to reference Borgström F (2010) The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. Osteoporos Int 21:495–505CrossRefPubMed Borgström F (2010) The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX. Osteoporos Int 21:495–505CrossRefPubMed
26.
go back to reference Baim S, Nattiv A, Siris ES (2010) Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 122:82CrossRefPubMed Baim S, Nattiv A, Siris ES (2010) Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 122:82CrossRefPubMed
27.
go back to reference Borgström F et al (2011) Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporos Int 22:955–965CrossRefPubMed Borgström F et al (2011) Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporos Int 22:955–965CrossRefPubMed
28.
go back to reference Ström O, Jönsson B, Kanis J (2013) Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Osteoporos Int 24:1491–1502CrossRefPubMed Ström O, Jönsson B, Kanis J (2013) Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Osteoporos Int 24:1491–1502CrossRefPubMed
29.
go back to reference Kim K et al (2014) Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm. Osteoporos Int 25:325–337CrossRefPubMed Kim K et al (2014) Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm. Osteoporos Int 25:325–337CrossRefPubMed
30.
go back to reference Liao E-Y et al (2002) Age-related bone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in Chinese women. Osteoporos Int 13:669–676CrossRefPubMed Liao E-Y et al (2002) Age-related bone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in Chinese women. Osteoporos Int 13:669–676CrossRefPubMed
31.
go back to reference Beck JR et al (1982) A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-making. Am J Med 73:889–897CrossRefPubMed Beck JR et al (1982) A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-making. Am J Med 73:889–897CrossRefPubMed
32.
go back to reference Fang X et al (2012) Frailty in relation to the risk of falls, fractures, and mortality in older Chinese adults: results from the Beijing Longitudinal Study of Aging. J Nutr Health Aging 16:903–907CrossRefPubMed Fang X et al (2012) Frailty in relation to the risk of falls, fractures, and mortality in older Chinese adults: results from the Beijing Longitudinal Study of Aging. J Nutr Health Aging 16:903–907CrossRefPubMed
33.
go back to reference Wang C-B et al (2013) Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone 56:147–153CrossRefPubMed Wang C-B et al (2013) Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone 56:147–153CrossRefPubMed
34.
go back to reference Kanis JA et al (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15:108–112CrossRefPubMed Kanis JA et al (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15:108–112CrossRefPubMed
35.
go back to reference Bliuc D et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521CrossRefPubMed Bliuc D et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521CrossRefPubMed
38.
go back to reference Sun S et al (2011) Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res 20:309–320CrossRefPubMed Sun S et al (2011) Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res 20:309–320CrossRefPubMed
39.
go back to reference Shih V et al (2012) Health state utility assessment for breast cancer. Value Health Regional Issues 1:93–97CrossRef Shih V et al (2012) Health state utility assessment for breast cancer. Value Health Regional Issues 1:93–97CrossRef
40.
go back to reference Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley, ChichesterCrossRef Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley, ChichesterCrossRef
41.
go back to reference Hagino H et al (2009) Sequential change in quality of life for patients with incident clinical fractures: a prospective study. Osteoporos Int 20:695–702CrossRefPubMed Hagino H et al (2009) Sequential change in quality of life for patients with incident clinical fractures: a prospective study. Osteoporos Int 20:695–702CrossRefPubMed
42.
go back to reference Buchebner D et al (2014) Vitamin D insufficiency over 5 years is associated with increased fracture risk—an observational cohort study of elderly women. Osteoporos Int 25:2767–2775CrossRefPubMed Buchebner D et al (2014) Vitamin D insufficiency over 5 years is associated with increased fracture risk—an observational cohort study of elderly women. Osteoporos Int 25:2767–2775CrossRefPubMed
44.
go back to reference Health U.D.o. and H. Services (2004) Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General Health U.D.o. and H. Services (2004) Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General
45.
go back to reference Melton LJ (2000) Who has osteoporosis? A conflict between clinical and public health perspectives. J Bone Miner Res 15:2309–2314CrossRefPubMed Melton LJ (2000) Who has osteoporosis? A conflict between clinical and public health perspectives. J Bone Miner Res 15:2309–2314CrossRefPubMed
46.
go back to reference Cong E, Walker MD (2014) The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture. Bone Res 2 Cong E, Walker MD (2014) The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture. Bone Res 2
47.
go back to reference Wang X-F, Seeman E (2012) Epidemiology and structural basis of racial differences in fragility fractures in Chinese and Caucasians. Osteoporos Int 23:411–422CrossRefPubMed Wang X-F, Seeman E (2012) Epidemiology and structural basis of racial differences in fragility fractures in Chinese and Caucasians. Osteoporos Int 23:411–422CrossRefPubMed
48.
go back to reference Xia WB et al (2012) Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res 27:125–129CrossRefPubMed Xia WB et al (2012) Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res 27:125–129CrossRefPubMed
49.
go back to reference Xu J et al (2013) Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population. Clin Interv Aging 8:789PubMedPubMedCentral Xu J et al (2013) Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population. Clin Interv Aging 8:789PubMedPubMedCentral
52.
go back to reference Kling JM, Clarke BL, Sandhu NP (2014) Osteoporosis prevention, screening, and treatment: a review. J Women’s Health 23:563–572CrossRef Kling JM, Clarke BL, Sandhu NP (2014) Osteoporosis prevention, screening, and treatment: a review. J Women’s Health 23:563–572CrossRef
Metadata
Title
Expected lifetime numbers, risks, and burden of osteoporotic fractures for 50-year old Chinese women: a discrete event simulation incorporating FRAX
Authors
Yawen Jiang
Weiyi Ni
Publication date
01-11-2016
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2016
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-015-0724-9

Other articles of this Issue 6/2016

Journal of Bone and Mineral Metabolism 6/2016 Go to the issue

List of Reviewers 2015-2016

List of reviewers 2015–2016

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.